Old Web
English
Sign In
Acemap
>
authorDetail
>
P. Wu
P. Wu
Pfizer
Gene expression
Immune system
Systemic lupus erythematosus
Interferon
Immunology
2
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FRI0382 Impact of Treatments on Major Immunologic Pathways in SLE Depends on Type I Interferon Signature: Analysis from Biomarkers of Lupus Disease (BOLD) Study
2014
Annals of the Rheumatic Diseases
Joan T. Merrill
Frederick W. Immermann
T. Zhou
Margot OToole
Maryann Whitley
Andrew A. Hill
Ying Zhang
D. von Schack
Padmalatha S. Reddy
J.L. Masferrer
S. Kamp
Joel M. Guthridge
Aikaterini Thanou
P. Wu
Theresa Paradis
William M. Mounts
Judith A. James
S. Sridharan
Show All
Source
Cite
Save
Citations (0)
FRI0003 Determination of interferon (IFN) signatures for sle patients may be critical for optimal treatment selection but depends on the genes chosen: report from the bold (biomarkers of lupus disease) study
2013
Annals of the Rheumatic Diseases
Andrew A. Hill
Frederick W. Immermann
Ying Zhang
Padmalatha S. Reddy
T. Zhou
M. O’Toole
Maryann Whitley
J. Masferrer
P. Wu
T. Paradis
S. Sridharan
Joan T. Merrill
Judith A. James
Show All
Source
Cite
Save
Citations (5)
1